Autoimmune diseases (ADs) are chronic conditions initiated by the loss of immunological tolerance to self-antigens and represent a heterogeneous group of disorders that afflict specific target organs or multiple organ systems [1]. The chronic nature of these diseases places a significant burden on the utilization of medical care, direct and indirect economic costs, and quality of life. The fact that ADs share several clinical signs and symptoms (i.e., subphenotypes), physiopathological mechanisms, and genetic factors has been called autoimmune tautology and indicates that they have common mechanisms [2–8].
In clinical practice, there are two conditions supporting this theory: polyautoimmunity and familial autoimmunity. Polyautoimmunity is the presence of two or more ADs in a single patient while familial autoimmunity occurs when different relatives from a nuclear family present with diverse ADs [4]. These conditions indicate that similar genetic, epigenetic, and environmental factors influence ADs [8].
In rhetoric, tautology (from Greek tauto, “the same” and logos, “word/idea”) is an obvious statement. In medical practice, Sjögren’s syndrome could be considered the “autoimmune diabetes” or the “celiac disease” of the salivary and lachrymal glands. In logic, tautology is a formula, which is true in every possible interpretation. Thus, autoimmune tautology means that an AD is similar to a second one, to a third one, and so on. Its formula is , where Vpq represents the symbol of tautology. ADs cannot be all identical because the target cell and the affected organ may differ from one AD to another one. In addition, trigger factors as well as the age at onset may vary among them and from one patient to another. Yet, autoimmune mechanisms of injury may be common including predisposing and protective factors. One step forward to the demonstration of this logically valid formula will be a new taxonomy of ADs based on common and specific subphenotypes that will allow us to predict and prevent them, tailor individual medical decisions, and provide personalized healthcare while facilitating patient’s participation in their treatment and eventual cure of their disease.
In Table 1, ten shared characteristics supporting the autoimmune tautology are summarized. In this special issue of Autoimmune Diseases, a dozen of papers are devoted to these characteristics. Evolution and genetics of ADs, including the biological significance of evolution in autoimmune phenomena, a meta-analysis of HLA class II in six ADs in Latin America, genetic factors of autoimmune thyroid diseases in Japanese, and an in silico approach of the autoimmune tautology are included. An updated review on epigenetics and ADs is also presented.
Environmental factors play an important role in the induction of ADs. This special issue also contains a very interesting hypothesis about local cartilage trauma as a pathogenic trigger factor of autoimmunity, a review about the induction of autoimmunity by microbial infections, and another one on the effect of selenium on HLA-DR expression of thyrocytes. How does age at onset influence the outcome of ADs is also reviewed, and an update on lupus nephritis is offered.
Last but not least, a careful analysis of concomitant ADs in patients with systemic lupus erythematosus, rheumatoid arthritis (RA), multiple sclerosis (MS), and systemic sclerosis is reported. Polyautoimmunity is the term proposed for this association of disorders, which encompasses the concept of a common origin for these diseases. A lack of association between spondyloarthropathies (SpAs) and ADs is described, highlighting the fact that SpAs correspond more to autoinflammatory diseases rather than to ADs.
We hope that readers of Autoimmune Diseases will find in this special issue not only accurate data and updated reviews on the common mechanisms of ADs, but also important questions to be resolved such as their missing heritability, the antagonisms of some disorders (i.e., RA and MS), their prevention, the effect of ethnicity, socioeconomic status and health care system on their outcome, and the role of the autoimmunologist, among others.
Juan-Manuel Anaya
Adriana Rojas-Villarraga
Mario García-Carrasco